CMSS Submits Comments to HHS-CMS on Sunshine Provisions
The Council of Medical Specialty Societies (CMSS), whose 37 member organizations represent 700,000 physicians in the US, recently…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
FDA Guidance for Industry Clinical Pharmacogenomics: Premarketing…
Pharmacogenomics (PGx) broadly refers to the study of variations of DNA and RNA characteristics as related to drug response. Drug…
Small Device Companies Taking Heat for Targeting Marketing But What About…
A recent article from the New York Times examined a brand of heart device that patients at a majohospital get. According to the…
NEJM: The Selling of Academic Detailing
Almost 50 years ago, U.S. Senator Estes Kefauver (D-TN) introduced legislation to regulate the drug industry because the Food and…
Survey Shows Physicians Have High Regards for Industry Interactions
Over the past several years, a number of media sources and so-called “investigative journalists” have published stories suggesting…
JAMA: The Inverse Logic of the Pharmaceutical Inverse Benefit “Law”
In today’s fast paced and rapidly changing medical environment, health care practitioners in every area—from primary care to…
ACC to Eliminate Outside Industry Supported CME Symposium at Future…
We think this week, that the American College of Cardiology (ACC) is forming a new business unit to produce promotional meetings…
FDA Webinar How to Report Your Local Sales Rep
As we noted last year, the Food and Drug Administration (FDA) launched “The Bad Ad Program,” which is designed to educate health…
Remove the Obstacles to Device Innovation
Over the past several months, there has been a large focus on the American medical device industry and regulatory approval and…
American Research and Competitiveness Act of 2010
Medical device and pharmaceutical companies face significant regulatory and legal obstacles in developing new and life-saving…